ZEJULA

At a glance

Key dates

1. Approval

   FDA approval date of this drug product.

   Apr 26, 2023

   3 yr 2 mo ago

2. Today

3. Patent 8071579 expires

   Listed method-of-use patent (U-2655) expiration.

   Aug 12, 2027

   in 1 yr 2 mo

4. Patent 8143241 expires

   Listed method-of-use patent (U-2655) expiration.

   Aug 12, 2027

   in 1 yr 2 mo

5. Patent 8436185 expires

   Listed drug substance patent expiration.

   Apr 24, 2029

   in 2 yr 11 mo

6. Patent 8071623 expires

   Listed drug substance patent expiration.

   Mar 27, 2031

   in 4 yr 10 mo

7. Patent 8859562 expires

   Listed method-of-use patent (U-2655) expiration.

   Aug 04, 2031

   in 5 yr 2 mo

8. Patent 11091459 expires

   Listed drug product patent expiration.

   Mar 27, 2038

   in 11 yr 11 mo

9. Patent 11673877 expires

   Listed drug product patent expiration.

   Mar 27, 2038

   in 11 yr 11 mo

10. Patent 11673877 expires

    Listed drug product patent expiration.

    Mar 27, 2038

    in 11 yr 11 mo

11. Patent 11730725 expires

    Listed drug product patent expiration.

    Jan 25, 2039

    in 12 yr 9 mo

Pharmaceutical detail

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

• ZEJULABrand (NDA)

  NDA 208447 · GLAXOSMITHKLINE

  2017

Listed patents (9)